Baudax Bio, Inc. (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0081
+0.0031 (62.00%)
Jul 16, 2024, 2:39 PM EDT - Market closed
Baudax Bio Employees
Baudax Bio had 9 employees as of December 31, 2022. The number of employees decreased by 71 or -88.75% compared to the previous year.
Employees
9
Change (1Y)
-71
Growth (1Y)
-88.75%
Revenue / Employee
$34,444
Profits / Employee
-$795,000
Market Cap
353.10K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 9 | -71 | -88.75% |
| Dec 31, 2021 | 80 | 23 | 40.35% |
| Dec 31, 2020 | 57 | 33 | 137.50% |
| Dec 31, 2019 | 24 | 4 | 20.00% |
| Dec 31, 2018 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
BXRXQ News
- 10 months ago - Baudax Bio Announces Corporate Update - GlobeNewsWire
- 10 months ago - Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors - GlobeNewsWire
- 11 months ago - Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 1 year ago - Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock - GlobeNewsWire
- 1 year ago - Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - GlobeNewsWire
- 1 year ago - Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 1 year ago - Baudax Bio shares jump on acquisition of TeraImmune - Market Watch
- 1 year ago - Baudax Bio Acquires TeraImmune, Inc. - GlobeNewsWire